Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wenqing Liang
Observed names:
Liang, Wenqing,
W. Liang
Institutions:
Zhejiang Chinese Medical University,
Zhoushan Hospital
Observed institutions:
Zhejiang Chinese Medical University,
First Affiliated Hospital of Guangzhou Medical University,
Zhoushan Hospital
ORCID:
0000-0002-4995-9402
Observed ORCID:
0000-0002-4995-9402
OpenAlex ID:
A5088009664
Mitochondrial Transplantation/Transfer: Promising Therapeutic Strategies for Spinal Cord Injury
2025
·
Xiaochun Xiong
, Chao Zhou
, et al.
·
Journal of Orthopaedic Translation
·
26
Nanotechnology in Orthopedic Care: Advances in Drug Delivery, Implants, and Biocompatibility Considerations
2025
·
Linying Xia
, Chao Zhou
, et al.
·
International Journal of Nanomedicine
·
18
PDF
Dual release scaffolds as a promising strategy for enhancing bone regeneration: an updated review
2025
·
Yongtao Zhang
, Chao Zhou
, et al.
·
Nanomedicine
·
11
Nanotechnology-Based Bone Regeneration in Orthopedics: A Review of Recent Trends
2024
·
Wenqing Liang
, Chao Zhou
, et al.
·
Nanomedicine
·
10
Synthetic Nanopillars for Stimulating Osteoblast Activity and Osteointegration in Bone-Related Disorders
2025
·
Wenqing Liang
, Chao Zhou
, et al.
·
International Journal of Nanomedicine
·
7
PDF
Advancements in Polymer-Based Nanocarriers for Controlled Release of Nitric Oxide: Clinical Applications and Future Prospects
2026
·
Haizhou Ying
, Chao Zhou
, et al.
·
International Journal of Nanomedicine
·
5
PDF
Pioneering nanomedicine in orthopedic treatment care: a review of current research and practices
2024
·
Wenqing Liang
, Chao Zhou
, et al.
·
Frontiers in Bioengineering and Biotechnology
·
3
EP05.02-009 Aumolertinib Versus Erlotinib/Chemotherapy for Neoadjuvant Treatment of Stage IIIA EGFR-mutant NSCLC (ANSWER)
2022
·
W. Liang
, E. Xu
, et al.
·
Journal of Thoracic Oncology
·
2
Nanotechnology revolutionizing osteosarcoma treatment: Advances in targeted kinase inhibitors
2025
·
Yongtao Zhang
, Chao Zhou
, et al.
·
Nanotechnology Reviews
·
1
PDF
1118P Real-world adjuvant treatment patterns in patients with stage I-III EGFR-mutated non-small cell lung cancer (NSCLC) in China: Interim analysis from the ADDRESS study
2022
·
W. Liang
, S. Jiang
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
12
Citation count:
83
H-index:
5
I10-index:
4
Year
Topic
Type